Skip to Main Content

Paper Details

Baseline neuropsychiatric symptoms and psychotropic medication use midway through data collection of the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort.
Alzheimers Dement
1
2023
AD, Alzheimer's Disease, Alzheimer's disease, EOAD, EOnonAD, NPS, early-onset, non-Alzheimer's disease, participants
Author NameAffiliation
Tatiana ForoudIndiana University School of Medicine
Malia RumbaughIndiana University School of Medicine
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Ranjan DuaraWien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center
Neill R Graff-RadfordMayo Clinic
Lawrence S HonigTaub Institute and Department of Neurology, Columbia University Irving Medical Center
Chiadi U OnyikeJohns Hopkins University School of Medicine
Raymond S TurnerGeorgetown University
Liana G ApostolovaAlzheimer's Therapeutic Research Institute, University of Southern California
Liana G ApostolovaCenter for Neuroimaging, Indiana University School of Medicine Indianapolis
  • 1 - 11

Datasets

Release 1.2